Human CD72 Antibody

R&D Systems, part of Bio-Techne | Catalog # AF5405

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
AF5405-100
AF5405-SP
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Species Reactivity

Human

Applications

Flow Cytometry, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Sheep IgG

View all CD72 Antibodies »

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human CD72
Arg117-Asp359
Accession # P21854

Specificity

Detects human CD72 in direct ELISAs.

Clonality

Polyclonal

Host

Sheep

Isotype

IgG

Scientific Data Images for Human CD72 Antibody

Detection of CD72 antibody in Human PBMCs antibody by Flow Cytometry.

Detection of CD72 in Human PBMCs by Flow Cytometry.

Human peripheral blood mononuclear cells (PBMCs) were stained with either (A) Sheep Anti-Human CD72 Affinity-Purified Polyclonal Antibody (Catalog # AF5405) or (B) Sheep IgG Isotype Control (Catalog # 5-001-A) followed by anti-Sheep IgG APC-conjugated Secondary Antibody (Catalog # F0127) and Mouse Anti-Human CD19 PE-conjugated Monoclonal Antibody (Catalog # FAB4867P). View our protocol for Staining Membrane-associated Proteins.

Applications for Human CD72 Antibody

Application
Recommended Usage

Flow Cytometry

0.25 µg/106 cells
Sample: Human PBMC

Western Blot

0.1 µg/mL
Sample: Recombinant Human CD72 (Catalog # 5405-CD)

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD72

CD72, also known as Lyb‑2, is a 40‑45 kDa type II transmembrane glycoprotein that plays a role in immune system regulation (1). Mature human CD72 consists of a 95 amino acid (aa) cytoplasmic domain with two immunoreceptor tyrosine‑based inhibitory motifs (ITIMs), a 21 aa transmembrane segment, and a 243 aa extracellular domain with a coiled‑coil domain and a C‑type lectin domain (2). Within the ECD, human CD72 shares 48% and 44% aa sequence identity with mouse and rat CD72, respectively. CD72 is expressed on B lineage cells, NK cells, monocytes, dendritic cells, and mast cells (2‑6). CD72 binds to CD5 with mouse/human cross‑reactivity and to Semaphorin 4D/CD100 (5, 7‑9). It associates with CD79A in the B cell antigen receptor (BCR) complex following antigen stimulation and dampens BCR signaling through interactions with the phosphatase SHP‑1 (10). CD72 ligation with antibodies or with Semaphorin 4D induces tyrosine dephosphorylation of the CD72 cytoplasmic domain and its dissociation from SHP‑1, leading to B cell proliferation (5, 9). Both CD72 and Semaphorin 4D are required for the maintenance of B cell anergy and the regulation of peripheral B cell tolerance as shown by the development of autoimmunity in mice that lack either molecule (10, 11). In addition to its negative regulation of BCR signaling, CD72 can induce positive signaling in B cells independent of the BCR (12). CD72 binding to Semaphorin 4D induces cytokine production by monocytes and dendritic cells, inhibits SCF R/c‑kit induced mast cell proliferation and activation, and inhibits the cytolytic activity of NK cells (4‑6). Semaphorin 4D is expressed on activated NK cells and contributes to the adhesive interaction between NK and CD72+ target cells leading to a more efficent killing and enhanced IFN-gamma secretion (13).

References

  1. Nykimbeng-Takwi, E. and S.P. Chapoval (2011) Immunol. Res. 50:10.
  2. Von Hoegen, I. et al. (1990) J. Immunol. 144:4870.
  3. Nakayama, E. et al. (1989) Proc. Natl. Acad. Sci. 86:1352.
  4. Alcon, V.L. et al. (2009) Eur. J. Immunol. 39:826.
  5. Ishida, I. et al. (2003) Int. Immunol. 15:1027.
  6. Kataoka, T.R. et al. (2010) J. Immunol. 184:2468.
  7. Van de Velde, H. et al. (1991) Nature 351:662.
  8. Luo, W. et al. (1992) J. Immunol. 148:1630.
  9. Kumanogoh, A. et al. (2000) Immunity 13:621.
  10. Kumanogoh, A. et al. (2005) Int. Immunol. 17:1277.
  11. Li, D. H.-H. et al. (2008) Arthritis Rheum. 58:3192.
  12. Wu, H.-J. et al. (2001) J. Immunol. 167:1263.
  13. Mizrahi, S. et al. (2007) PLoS ONE 9:e818.

Alternate Names

CD72, Ly-19.2, Ly-32.2, Lyb-2

Entrez Gene IDs

971 (Human); 12517 (Mouse)

Gene Symbol

CD72

UniProt

P21854

Additional CD72 Products

Product Documents for Human CD72 Antibody

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Human CD72 Antibody

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.